| P2093 | author name string | Rémy Burcelin | |
| P2860 | cites work | Development of the human infant intestinal microbiota | Q21003936 |
| | Inflammation and insulin resistance | Q22241893 |
| | Enterotypes of the human gut microbiome | Q24489818 |
| | Obesity alters gut microbial ecology | Q24531503 |
| | Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse | Q24564225 |
| | B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies | Q24598772 |
| | A human gut microbial gene catalogue established by metagenomic sequencing | Q24618931 |
| | A core gut microbiome in obese and lean twins | Q24649648 |
| | Mechanisms underlying the resistance to diet-induced obesity in germ-free mice | Q24676006 |
| | Modulation of the gut microbiota by nutrients with prebiotic properties: consequences for host health in the context of obesity and metabolic syndrome | Q27006454 |
| | An obesity-associated gut microbiome with increased capacity for energy harvest | Q27860515 |
| | Inflammation and metabolic disorders | Q27860923 |
| | Obesity is associated with macrophage accumulation in adipose tissue | Q27860976 |
| | The gut microbiota as an environmental factor that regulates fat storage | Q28131676 |
| | Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity | Q28512778 |
| | Metabolic endotoxemia initiates obesity and insulin resistance | Q29547720 |
| | The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice | Q29614457 |
| | Factors influencing the composition of the intestinal microbiota in early infancy | Q29614578 |
| | Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5 | Q29615053 |
| | Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice | Q29615055 |
| | Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters | Q29617381 |
| | CCR2 modulates inflammatory and metabolic effects of high-fat feeding | Q29622869 |
| | Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells | Q30476839 |
| | Composition, variability, and temporal stability of the intestinal microbiota of the elderly | Q30499047 |
| | Myeloid differentiation factor 88 (MyD88)-deficiency increases risk of diabetes in mice | Q33687009 |
| | Microbes in gastrointestinal health and disease | Q33943525 |
| | Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. | Q34006689 |
| | The endocannabinoid system links gut microbiota to adipogenesis | Q34078880 |
| | Gut microbiota is a key modulator of insulin resistance in TLR 2 knockout mice | Q34097751 |
| | Toll-like receptor 2-dependent bacterial sensing does not occur via peptidoglycan recognition | Q34166263 |
| | Childhood obesity, other cardiovascular risk factors, and premature death | Q34220417 |
| | Patterns of early gut colonization shape future immune responses of the host | Q34221994 |
| | Review article: diabetes, genetics and ethnicity | Q34459597 |
| | Fecal microflora in healthy infants born by different methods of delivery: permanent changes in intestinal flora after cesarean delivery | Q34756399 |
| | Normalization of obesity-associated insulin resistance through immunotherapy | Q34994222 |
| | NOD1 activators link innate immunity to insulin resistance | Q35180089 |
| | Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. | Q35693573 |
| | Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota | Q35799019 |
| | Debugging how bacteria manipulate the immune response. | Q36739044 |
| | Nod-like proteins in inflammation and disease. | Q37045747 |
| | Tissue factor and PAR1 promote microbiota-induced intestinal vascular remodelling | Q37451950 |
| | Epigenetic mechanisms elicited by nutrition in early life | Q37946981 |
| | TLR5 or NLRC4 is necessary and sufficient for promotion of humoral immunity by flagellin | Q39632623 |
| | NOD2 Activation Induces Muscle Cell-Autonomous Innate Immune Responses and Insulin Resistance | Q39647567 |
| | The gut microbiota modulates host energy and lipid metabolism in mice | Q39993460 |
| | Heterogeneous metabolic adaptation of C57BL/6J mice to high-fat diet | Q43908141 |
| | Transcript profiling suggests that differential metabolic adaptation of mice to a high fat diet is associated with changes in liver to muscle lipid fluxes | Q45065666 |
| | An evaluation of the effects of Lactobacillus ingluviei on body weight, the intestinal microbiome and metabolism in mice | Q47348195 |
| | Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor. | Q51498948 |
| | Growth-promoting effects of single-dose intragastrically administered probiotics in chickens. | Q51723425 |
| | C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet | Q58106596 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 300-307 | |
| P577 | publication date | 2012-10-01 | |
| P1433 | published in | Physiology | Q1091804 |
| P1476 | title | Regulation of metabolism: a cross talk between gut microbiota and its human host | |
| P478 | volume | 27 | |